Myths vs facts: APOE and Wechseljahre

Menopause (Wechseljahre) is a period of hormonal transition that increases the risk of cognitive decline and cardiovascular disease. The APOE genotype (ε2, ε3, ε4) influences lipid metabolism and is the strongest known genetic risk factor for Alzheimer's disease. A common myth is that women with APOE ε4 will inevitably develop dementia after menopause. Fact: APOE ε4 raises risk but is not deterministic; many ε4 carriers remain healthy. Additionally, the drop in estrogen during menopause may reduce neuroprotection, potentially more pronounced in ε4 carriers. However, evidence for direct clinical recommendations from APOE testing alone is weak. Most studies are associative (GWAS) and not causal. Consumer APOE tests should not be used for medical diagnosis or to guide hormone therapy decisions. Instead, a healthy lifestyle, cognitive engagement, and regular medical check-ups are advisable. The predictive power of a single gene is limited – menopause and cognitive health are multifactorial.